Newfoundland Von Willebrand's Disease Type I: What the Genetics Actually Determine

Type I von Willebrand's disease in the breeds where it has been genetically characterised follows an autosomal pattern, meaning the responsible gene is not on a sex chromosome and both male and female dogs are equally likely to be affected or to carry it. Depending on the specific population and how the trait behaves within it, a dog can be genetically clear, a carrier with no or minimal clinical signs, or affected with the reduced clotting protein levels that define the disease, and DNA testing can distinguish between these categories directly rather than relying on inferred risk from a pedigree alone.

This is meaningfully different from diagnosing the disease clinically through a blood test measuring clotting protein activity at a single point in time, which shows the current level in that individual dog but does not on its own reveal the full genetic picture, including carrier status in a dog whose levels currently look normal. A DNA test targets the actual genetic variant, which means it can identify a carrier dog who will never show a clinical sign in its own life but who can still pass the variant to some proportion of its puppies, an outcome invisible to a clotting activity blood test alone.

For Type I specifically, clinical severity in an affected dog also varies considerably, and a proportion of affected dogs show few or no clinical signs under ordinary circumstances despite testing as affected, only becoming apparent during a significant injury or surgical procedure. This variability is part of why genetic testing, rather than waiting for a clinical event to reveal the diagnosis, has become the standard recommended approach in breeds where the test is available and validated.

A genetic result is only useful if it is correctly translated into an actual pairing decision, and this is where the practical value of testing lives.

If you think your Newfoundland has von willebrand's disease, the plan is three steps: write down what you have seen and when it started, book a veterinary appointment rather than waiting for the next flare, and take video of the behaviour or symptom before you go — the thing you are worried about rarely happens in the consulting room. Screening in the parents covers hip dysplasia, subaortic stenosis, dilated cardiomyopathy.

What the vet visit should produce is a diagnosis and a written plan, not just reassurance: what is being ruled out, what the monitoring interval is, and which signs mean you come back sooner. Ask what the treatment costs across a year rather than per visit, because that is the number that decides whether you are managing this condition or reacting to it.

Between appointments, keep a short log — dates, what you saw, what changed. It is the single most useful thing an owner brings to a follow-up, and for von willebrand's disease it is often what separates a clear pattern from a guess.